NeuroPace, Inc.

$15.86

+$0.69 (+4.55%)

Jan 5, 2026

Price History (1Y)

Analysis

NeuroPace, Inc. is a healthcare company in the medical devices industry with a market capitalization of $528.26 million and 209 employees. The company's financial health is characterized by negative profitability metrics, with gross margin at 76.8%, operating margin at -9.5%, and profit margin at -25.3%. Additionally, NeuroPace has reported significant losses in the past year, including a net income of -$23,986,000 and EBITDA of -$18,018,000. NeuroPace's valuation is influenced by its negative P/E ratio (-26.11), high debt to equity ratio (384.39), and price to sales ratio (5.57). The company has also reported revenue growth of 29.9% year-over-year, although earnings growth data is not available.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Visit website →

Key Statistics

Market Cap
$528.26M
P/E Ratio
N/A
52-Week High
$18.98
52-Week Low
$7.56
Avg Volume
210.93K
Beta
1.86

Company Info

Exchange
NGM
Country
United States
Employees
209